JP2014224759A5 - - Google Patents

Download PDF

Info

Publication number
JP2014224759A5
JP2014224759A5 JP2013104124A JP2013104124A JP2014224759A5 JP 2014224759 A5 JP2014224759 A5 JP 2014224759A5 JP 2013104124 A JP2013104124 A JP 2013104124A JP 2013104124 A JP2013104124 A JP 2013104124A JP 2014224759 A5 JP2014224759 A5 JP 2014224759A5
Authority
JP
Japan
Prior art keywords
psychiatric
neurological disorder
biomarker
free
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013104124A
Other languages
English (en)
Japanese (ja)
Other versions
JP6205175B2 (ja
JP2014224759A (ja
Filing date
Publication date
Priority claimed from JP2013104124A external-priority patent/JP6205175B2/ja
Priority to JP2013104124A priority Critical patent/JP6205175B2/ja
Application filed filed Critical
Priority to US14/891,301 priority patent/US10041954B2/en
Priority to EP14797879.5A priority patent/EP3002588B1/en
Priority to PCT/JP2014/057227 priority patent/WO2014185145A1/ja
Publication of JP2014224759A publication Critical patent/JP2014224759A/ja
Publication of JP2014224759A5 publication Critical patent/JP2014224759A5/ja
Priority to US15/645,907 priority patent/US20180120328A1/en
Publication of JP6205175B2 publication Critical patent/JP6205175B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013104124A 2013-05-16 2013-05-16 精神・神経疾患バイオマーカー Expired - Fee Related JP6205175B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2013104124A JP6205175B2 (ja) 2013-05-16 2013-05-16 精神・神経疾患バイオマーカー
US14/891,301 US10041954B2 (en) 2013-05-16 2014-03-18 Biomarker for psychiatric and neurological disorders
EP14797879.5A EP3002588B1 (en) 2013-05-16 2014-03-18 Use of a biomarker for diagnosing schizophrenia
PCT/JP2014/057227 WO2014185145A1 (ja) 2013-05-16 2014-03-18 精神・神経疾患バイオマーカー
US15/645,907 US20180120328A1 (en) 2013-05-16 2017-07-10 Biomarker for psychiatric and neurological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013104124A JP6205175B2 (ja) 2013-05-16 2013-05-16 精神・神経疾患バイオマーカー

Publications (3)

Publication Number Publication Date
JP2014224759A JP2014224759A (ja) 2014-12-04
JP2014224759A5 true JP2014224759A5 (cg-RX-API-DMAC10.html) 2016-07-28
JP6205175B2 JP6205175B2 (ja) 2017-10-04

Family

ID=51898130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013104124A Expired - Fee Related JP6205175B2 (ja) 2013-05-16 2013-05-16 精神・神経疾患バイオマーカー

Country Status (4)

Country Link
US (2) US10041954B2 (cg-RX-API-DMAC10.html)
EP (1) EP3002588B1 (cg-RX-API-DMAC10.html)
JP (1) JP6205175B2 (cg-RX-API-DMAC10.html)
WO (1) WO2014185145A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6205175B2 (ja) 2013-05-16 2017-10-04 株式会社Ｒｅｓｖｏ 精神・神経疾患バイオマーカー
JP7301327B2 (ja) * 2017-11-24 2023-07-03 学校法人 京都産業大学 マウスのうつ及び／又は不安症バイオマーカー
JP6737995B2 (ja) * 2018-11-29 2020-08-12 株式会社Ｒｅｓｖｏ 精神疾患発症危険状態の診断用バイオマーカー
GB202000634D0 (en) * 2020-01-15 2020-02-26 Nat Institute Of Mental Health Diagnostic method
JP6817666B2 (ja) * 2020-06-24 2021-01-20 株式会社Ｒｅｓｖｏ 精神疾患発症危険状態の診断用バイオマーカー

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243558A (en) * 1991-07-15 1994-06-27 Wellcome Found Recombinant primate antibodies and their production
US20060191026A1 (en) * 2005-02-18 2006-08-24 Origen Therapeutics, Inc. Tissue specific expression of antibodies in chickens
AU2003298607B9 (en) * 2002-10-29 2011-08-04 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
HRP20140673T1 (hr) * 2006-02-17 2014-10-10 Atsuo Sekiyama Indikator biološkog materijala i postupak mjerenja biološkog materijala
GB0724735D0 (en) 2007-12-19 2008-01-30 Psynova Neurotech Ltd Methods and biomarkers for diagnosing and monitoring psychotic disorders
US20120178118A1 (en) * 2010-12-06 2012-07-12 Bo Pi Biomarkers for monitoring treatment of neuropsychiatric diseases
WO2010141716A2 (en) * 2009-06-05 2010-12-09 Mayo Foundation For Medical Education And Research Methods and materials for diagnosing light chain amyloidosis
GB0915736D0 (en) * 2009-09-09 2009-10-07 Cambridge Entpr Ltd Biomarkers
GB201008340D0 (en) * 2010-05-19 2010-07-07 Cambridge Entpr Ltd Biomarkers
JP5641471B2 (ja) 2010-06-29 2014-12-17 国立大学法人名古屋大学 統合失調症マーカー及びその利用
US20120238837A1 (en) * 2011-03-16 2012-09-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions
JP6205175B2 (ja) 2013-05-16 2017-10-04 株式会社Ｒｅｓｖｏ 精神・神経疾患バイオマーカー

Similar Documents

Publication Publication Date Title
JP6430413B2 (ja) アルツハイマー病の診断のための方法と組成物
EP3504553B1 (en) System and method for analysis of biological data
US10247730B2 (en) Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient
EP4045912A1 (en) Apparatuses and methods for detection of pancreatic cancer
Lee et al. Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus
Malekzadeh et al. Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases
Yang et al. Development and evaluation of up-converting phosphor technology-based lateral flow assay for quantitative detection of NT-proBNP in blood
Kruse et al. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
WO2011136080A1 (ja) 動脈硬化の評価法
CN106537146A (zh) 生物标志
WO2017184895A2 (en) Compositions and methods related to κ180 dimethylated h1.0 protein
JP2021185371A (ja) 心不全におけるスタチン治療階層化のためのマーカー
CN103823058B (zh) 血清中抗原类蛋白的化学发光蛋白芯片方法和试剂盒
Chen et al. Magnetic beads based immunoaffinity capillary electrophoresis of total serum IgE with laser-induced fluorescence detection
Wang et al. Determination of plasma β-amyloids by rolling circle amplification chemiluminescent immunoassay for noninvasive diagnosis of Alzheimer’s disease
TWI655433B (zh) 川崎氏症之診斷與治療
JP6205175B2 (ja) 精神・神経疾患バイオマーカー
Valentina et al. Cytokine detection and simultaneous assessment of rheumatoid factor interference in human serum and synovial fluid using high-sensitivity protein arrays on plasmonic gold chips
Nguyen et al. Capillary electrophoresis-laser-induced fluorescence (CE-LIF)-based immunoassay for quantifying antibodies against cyclic citrullinated peptides
WO2015019979A1 (ja) 統合失調症に関するバイオマーカー
Ourradi et al. Development and validation of novel biomarker assays for osteoarthritis
Lee et al. Singlicate bead-based immunoassay for biomarker quantitation in sub-microliter volume sample
CN111562390A (zh) 一种神经精神性狼疮的诊断标志物及其检测试剂盒
JP7315965B2 (ja) ウィルス性肝癌の検出方法
JP7307479B2 (ja) ＩｇＡ腎症診断用キット